Skip to main content
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
FDA Updates
The Effect of Atazanavir on Doxorubicin Pharmacokinetics: A Case Report
Neha Umesh Sheth, PharmD, AAHIVP, BCPS, Steven Gilmore, PharmD, BCOP, Kenneth S. Bauer Jr, PharmD, PhD, Saranya Chumsri, MD
Read More
FDA Updates
Palifermin Use for the Prevention of Chemotherapy-Induced Oral Mucositis in Anal Cancer: A Case Report
Amanda Brahim, PharmD, BCPS, Mohammed Ibrahim, PharmD, CRPH, BCOP, BCPS, Tim Nguyen, MD, Zahava Ohana, PharmD
Read More
From the Literature
Rituximab Maintenance Prolongs Progression-Free Survival in Patients with Relapsed Follicular Lymphoma Undergoing High-Dose Chemotherapy and Autologous Transplantation
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature
Crizotinib Superior to Standard Chemotherapy in Patients with ALK-Positive Lung Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature
Neoadjuvant Lapatinib and Trastuzumab with Hormonal Therapy and No Chemotherapy Beneficial in Patients with HER2 Breast Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Original Research
Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer
Robert Mancini, PharmD, BCOP, FHOPA, Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN
Read More
FDA Updates
Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma
Michael K.K. Wong, MD, PhD, FRCPC, Anthony Jarkowski III, PharmD, BCOP
Read More
Letters to the Editor
Impact of Pharmacists’ Intervention in Altering Prescribing Patterns for the Treatment of VTE in Patients with Cancer
Read More
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Page 188 of 200
Results 1871 - 1880 of 1993